Patient education and health promotion can be effective in Parkinson's disease: a randomized controlled trial. PROPATH Advisory Board.
Identifieur interne : 004114 ( Main/Exploration ); précédent : 004113; suivant : 004115Patient education and health promotion can be effective in Parkinson's disease: a randomized controlled trial. PROPATH Advisory Board.
Auteurs : E B Montgomery [Canada] ; A. Lieberman ; G. Singh ; J F FriesSource :
- The American journal of medicine [ 0002-9343 ] ; 1994.
English descriptors
- KwdEn :
- Activities of Daily Living, Aged, Cost-Benefit Analysis, Health Promotion (organization & administration), Health Services (utilization), Humans, Levodopa (therapeutic use), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson Disease (psychology), Parkinson Disease (rehabilitation), Patient Compliance, Patient Education as Topic (organization & administration), Prognosis, Program Evaluation, Quality of Life, Severity of Illness Index, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Levodopa.
- drug therapy : Parkinson Disease.
- organization & administration : Health Promotion, Patient Education as Topic.
- physiopathology : Parkinson Disease.
- psychology : Parkinson Disease.
- rehabilitation : Parkinson Disease.
- utilization : Health Services.
- Activities of Daily Living, Aged, Cost-Benefit Analysis, Humans, Patient Compliance, Prognosis, Program Evaluation, Quality of Life, Severity of Illness Index, Treatment Outcome.
Abstract
We performed a randomized controlled trial to evaluate the effectiveness of a patient education and health promotion program in the treatment of Parkinson's disease. The health promotion program (PROPATH) was designed to improve health confidence, provide information and support, improve physical function through exercise, and work with the physician to optimize medical treatment and compliance. The intervention was delivered by mail, with disease assessment questionnaires completed by patient or caregiver at 0, 2, 4, and 6 months, with computer-generated reports and individualized recommendation letters returned to patients and reports to physicians. Two hundred ninety patients completed the 6-month trial, 140 patients in the intervention group and 150 in a control group of patients who received only questionnaires. The intervention group had significantly increased exercise, decreased "time off" and percentage of time off, reduced side effects, and decreased summary Parkinson's scores by approximately 10% (P > 0.05). Twelve of 13 variables showed differences favoring the intervention group. The rate of progression of summary scores became essentially flat during the program for the intervention group and continued to rise sharply for controls (P > 0.01). Levodopa dose rose for controls and slightly decreased for the intervention group. Doctor visits, hospital days, and sick days were reduced in the intervention group. The quality-of-life assessment demonstrated improvement in patient global, self-efficacy scores, and spouse or caregiver assessments. We conclude that a low-cost patient education program provides a useful adjunct to medical therapy of Parkinson's disease, may reduce costs, and can improve intermediate term outcomes.
PubMed: 7977431
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001941
- to stream PubMed, to step Curation: 001941
- to stream PubMed, to step Checkpoint: 001941
- to stream Ncbi, to step Merge: 002441
- to stream Ncbi, to step Curation: 002441
- to stream Ncbi, to step Checkpoint: 002441
- to stream Main, to step Merge: 004855
- to stream Main, to step Curation: 004114
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patient education and health promotion can be effective in Parkinson's disease: a randomized controlled trial. PROPATH Advisory Board.</title><author><name sortKey="Montgomery, E B" sort="Montgomery, E B" uniqKey="Montgomery E" first="E B" last="Montgomery">E B Montgomery</name><affiliation wicri:level="1"><nlm:affiliation>University of Vancouver, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Vancouver</wicri:regionArea></affiliation></author><author><name sortKey="Lieberman, A" sort="Lieberman, A" uniqKey="Lieberman A" first="A" last="Lieberman">A. Lieberman</name></author><author><name sortKey="Singh, G" sort="Singh, G" uniqKey="Singh G" first="G" last="Singh">G. Singh</name></author><author><name sortKey="Fries, J F" sort="Fries, J F" uniqKey="Fries J" first="J F" last="Fries">J F Fries</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1994">1994</date><idno type="RBID">pubmed:7977431</idno><idno type="pmid">7977431</idno><idno type="wicri:Area/PubMed/Corpus">001941</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001941</idno><idno type="wicri:Area/PubMed/Curation">001941</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001941</idno><idno type="wicri:Area/PubMed/Checkpoint">001941</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001941</idno><idno type="wicri:Area/Ncbi/Merge">002441</idno><idno type="wicri:Area/Ncbi/Curation">002441</idno><idno type="wicri:Area/Ncbi/Checkpoint">002441</idno><idno type="wicri:doubleKey">0002-9343:1994:Montgomery E:patient:education:and</idno><idno type="wicri:Area/Main/Merge">004855</idno><idno type="wicri:Area/Main/Curation">004114</idno><idno type="wicri:Area/Main/Exploration">004114</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Patient education and health promotion can be effective in Parkinson's disease: a randomized controlled trial. PROPATH Advisory Board.</title><author><name sortKey="Montgomery, E B" sort="Montgomery, E B" uniqKey="Montgomery E" first="E B" last="Montgomery">E B Montgomery</name><affiliation wicri:level="1"><nlm:affiliation>University of Vancouver, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>University of Vancouver</wicri:regionArea></affiliation></author><author><name sortKey="Lieberman, A" sort="Lieberman, A" uniqKey="Lieberman A" first="A" last="Lieberman">A. Lieberman</name></author><author><name sortKey="Singh, G" sort="Singh, G" uniqKey="Singh G" first="G" last="Singh">G. Singh</name></author><author><name sortKey="Fries, J F" sort="Fries, J F" uniqKey="Fries J" first="J F" last="Fries">J F Fries</name></author></analytic><series><title level="j">The American journal of medicine</title><idno type="ISSN">0002-9343</idno><imprint><date when="1994" type="published">1994</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activities of Daily Living</term><term>Aged</term><term>Cost-Benefit Analysis</term><term>Health Promotion (organization & administration)</term><term>Health Services (utilization)</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson Disease (psychology)</term><term>Parkinson Disease (rehabilitation)</term><term>Patient Compliance</term><term>Patient Education as Topic (organization & administration)</term><term>Prognosis</term><term>Program Evaluation</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Health Promotion</term><term>Patient Education as Topic</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Health Services</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Activities of Daily Living</term><term>Aged</term><term>Cost-Benefit Analysis</term><term>Humans</term><term>Patient Compliance</term><term>Prognosis</term><term>Program Evaluation</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We performed a randomized controlled trial to evaluate the effectiveness of a patient education and health promotion program in the treatment of Parkinson's disease. The health promotion program (PROPATH) was designed to improve health confidence, provide information and support, improve physical function through exercise, and work with the physician to optimize medical treatment and compliance. The intervention was delivered by mail, with disease assessment questionnaires completed by patient or caregiver at 0, 2, 4, and 6 months, with computer-generated reports and individualized recommendation letters returned to patients and reports to physicians. Two hundred ninety patients completed the 6-month trial, 140 patients in the intervention group and 150 in a control group of patients who received only questionnaires. The intervention group had significantly increased exercise, decreased "time off" and percentage of time off, reduced side effects, and decreased summary Parkinson's scores by approximately 10% (P > 0.05). Twelve of 13 variables showed differences favoring the intervention group. The rate of progression of summary scores became essentially flat during the program for the intervention group and continued to rise sharply for controls (P > 0.01). Levodopa dose rose for controls and slightly decreased for the intervention group. Doctor visits, hospital days, and sick days were reduced in the intervention group. The quality-of-life assessment demonstrated improvement in patient global, self-efficacy scores, and spouse or caregiver assessments. We conclude that a low-cost patient education program provides a useful adjunct to medical therapy of Parkinson's disease, may reduce costs, and can improve intermediate term outcomes.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Fries, J F" sort="Fries, J F" uniqKey="Fries J" first="J F" last="Fries">J F Fries</name><name sortKey="Lieberman, A" sort="Lieberman, A" uniqKey="Lieberman A" first="A" last="Lieberman">A. Lieberman</name><name sortKey="Singh, G" sort="Singh, G" uniqKey="Singh G" first="G" last="Singh">G. Singh</name></noCountry><country name="Canada"><noRegion><name sortKey="Montgomery, E B" sort="Montgomery, E B" uniqKey="Montgomery E" first="E B" last="Montgomery">E B Montgomery</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004114 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004114 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:7977431
|texte= Patient education and health promotion can be effective in Parkinson's disease: a randomized controlled trial. PROPATH Advisory Board.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:7977431" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |